GL1X · GenesisL1 explorer

MolNFT v1 · #15071 · protein

Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy

1MT7 · Protease retropepsin: “Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy”. X-ray diffraction. MolNFT v1 #15071 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1MT7
Type
protein
Length
206 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease retropepsin; Substrate analogue
EC
3.4.23.16
UniProt
P03369, Q9YYH6

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease retropepsin (EC 3.4.23.16)protein997% helix, 55% strandP03369
PSubstrate analogueprotein80% helix, 38% strandQ9YYH6

Ligands and binding sites

  • ACT · Acetate ion · additive · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

3 interfaces between chains.

  • A–B · 1822 Ų buried · 36 hydrogen bonds · protein-protein
  • A–P · 485 Ų buried · 12 hydrogen bonds · protein-protein
  • B–P · 465 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 1MT7 · Viability of a drug-resistant HIV-1 protease mutant: structural insights for better… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.